Dmitry Balyasny’s Rallybio RLYB Stock Holding History

Dmitry Balyasny’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-376,573	Closed	-$3.38M	–	3427
2026 Q1	$3.38M	Buy	+376,573	New	+$2.57M	﹤0.01%	1541

Other funds holding RLYB

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

Dmitry Balyasny's RLYB Position: Q2 2026 in Review

Dmitry Balyasny sold out of Rallybio (RLYB) in Q2 2026, closing a stake of 376,573 shares — an estimated $3.38M sold.

Dmitry Balyasny first reported a position in RLYB in Q1 2026 and held it in 1 quarter. The position peaked at $3.38M in Q1 2026. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

Dmitry Balyasny reported no remaining Rallybio position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 376,573 Rallybio shares in Q2 2026, an estimated $3.38M.
Dmitry Balyasny first reported a position in Rallybio in Q1 2026 and held it in 1 quarter.
Dmitry Balyasny's Rallybio position peaked at $3.38M in Q1 2026.
37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.